MOSPD1

Model summary

A human regulatory scaffold that uses an Ig-like beta-sandwich core and a major sperm protein domain to mediate multivalent protein binding and assemble transcriptional control complexes. By shuttling between the perinuclear cytoplasm and nucleus, it organizes co-regulatory assemblies that can either stimulate or repress RNA polymerase II–dependent transcription, likely tuning gene expression through context-dependent partner recruitment and nucleocytoplasmic trafficking.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The N-terminal two-thirds of the polypeptide (residues 1–140) belong to IPR008962 (PapD-like superfamily), and residues 17–136 fall within IPR013783 (Immunoglobulin-like fold). These overlapping superfamily signatures indicate a beta-sandwich scaffold optimized for avid protein–protein interactions rather than catalysis. Embedded within this fold, residues 16–143 form IPR000535 (Major sperm protein, MSP domain), a hallmark of MSP-domain-containing proteins that use Ig-like beta-sandwiches to bind diverse partners and assemble higher-order complexes. The full-length sequence is classified by IPR039283 (Motile sperm domain-containing protein 1/3 family, residues 1–213), which ties this architecture to a family known for regulatory scaffolding and nucleic acid-associated functions. The ordered layout—an Ig-like/PapD-like core that houses an MSP domain and extends to a family-specific C-terminal region—creates a modular interaction platform that causes broad binding capacity and supports transcriptional regulation.

2. 02

   This domain architecture dictates the molecular function.

   The Ig-like/PapD-like scaffold and MSP domain together generate multivalent interfaces that mediate GO:0005515 protein binding. The absence of catalytic motifs and the presence of a versatile binding core argue that regulation occurs through assembly and positioning of other macromolecules rather than direct enzymatic activity.

3. 03

   From this binding-centric foundation, I infer dual transcriptional control.

   The same scaffold that recruits partners can assemble co-regulatory complexes that either stimulate or repress RNA polymerase II output. This explains participation in both GO:0045944 positive regulation of transcription by RNA polymerase II and GO:0000122 negative regulation of transcription by RNA polymerase II. The ability to toggle between activation and repression likely arises from context-dependent partner selection by the MSP domain and Ig-like fold, enabling the protein to bridge transcription factors and chromatin-associated assemblies.

4. 04

   Cellular localization follows from function and architecture.

   Transcriptional regulation requires nuclear access, consistent with GO:0005634 nucleus. Regulatory scaffolds of this type often concentrate in the perinuclear cytoplasm where they traffic to and from the nucleus, aligning with GO:0048471 perinuclear region of cytoplasm. The soluble, non-membranous nature of the Ig-like/MSP framework further supports a nucleocytoplasmic distribution with enrichment near the nuclear envelope.

5. 05

   Mechanistically, I hypothesize that the MSP domain nucleates assemblies that couple cytoskeletal and perinuclear positioning to gene regulatory outputs.

   In human cells, this could entail transient complexes with RNA polymerase II machinery and chromatin remodelers that shuttle through the perinuclear space. The scaffold likely binds transcription factors and co-regulators, switching between activation and repression depending on partner availability and post-translational cues. Candidate partners include Pol II general factors and mediator components for activation; histone deacetylases and nucleosome remodelers for repression. Perinuclear enrichment suggests interactions with nuclear transport machinery and cytoskeletal adaptors that coordinate nuclear import and transcriptional readiness.